Get App Open
In App
News on WhatsApp
News on WhatsApp
Open App

Alpa Laboratories Ltd.

BSE: 532878 | NSE: ALPA |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE385I01010 | SECTOR: Pharmaceuticals & Drugs

BSE Live

Apr 17, 16:01
68.75 -0.30 (-0.43%)
Volume
AVERAGE VOLUME
5-Day
4,323
10-Day
6,791
30-Day
5,788
825
  • Prev. Close

    69.05

  • Open Price

    68.50

  • Bid Price (Qty.)

    68.00 (25)

  • Offer Price (Qty.)

    68.75 (5)

NSE Live

Apr 17, 15:56
68.82 -0.75 (-1.08%)
Volume
AVERAGE VOLUME
5-Day
17,600
10-Day
66,773
30-Day
41,030
18,810
  • Prev. Close

    69.57

  • Open Price

    68.55

  • Bid Price (Qty.)

    68.82 (120)

  • Offer Price (Qty.)

    0.00 (0)

Financials

Profit & Loss account of Alpa Laboratories (in Rs. Cr.) Mar 25 Mar 24 Mar 23 Mar 22 Mar 21  
  12 mths 12 mths 12 mths 12 mths 12 mths  
INCOME  
Revenue From Operations [Gross] 111.63 107.92 92.41 110.51 96.41  
Less: Excise/Sevice Tax/Other Levies 0.00 0.00 0.00 0.00 0.00  
Revenue From Operations [Net] 111.63 107.92 92.41 110.51 96.41  
Total Operating Revenues 112.45 108.74 92.96 112.27 97.55  
Other Income 23.31 14.87 9.41 10.79 4.41  
Total Revenue 135.76 123.61 102.36 123.06 101.96  
EXPENSES  
Cost Of Materials Consumed 70.72 62.88 52.45 63.42 54.23  
Purchase Of Stock-In Trade 0.93 5.80 1.22 5.82 6.39  
Operating And Direct Expenses 5.85 6.57 6.55 6.31 5.29  
Changes In Inventories Of FG,WIP And Stock-In Trade -1.45 -0.64 1.27 0.53 -1.15  
Employee Benefit Expenses 14.37 13.26 12.17 11.93 11.75  
Finance Costs 0.27 0.39 0.22 0.24 0.10  
Depreciation And Amortisation Expenses 2.20 1.95 1.33 1.66 1.23  
Other Expenses 17.04 12.73 11.21 13.56 13.34  
Total Expenses 109.92 102.94 86.43 103.48 91.17  
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax 25.84 20.67 15.93 19.58 10.79  
Exceptional Items 0.00 0.00 0.00 0.00 0.00  
Profit/Loss Before Tax 25.84 20.67 15.93 19.58 10.79  
Tax Expenses-Continued Operations  
Current Tax 4.06 3.78 3.60 3.10 2.50  
Less: MAT Credit Entitlement 0.00 0.00 0.00 0.00 0.00  
Deferred Tax 2.10 0.11 -0.29 2.35 1.14  
Tax For Earlier Years 0.00 0.00 0.00 0.00 -0.11  
Total Tax Expenses 6.16 3.90 3.31 5.45 3.53  
Profit/Loss After Tax And Before ExtraOrdinary Items 19.68 16.78 12.62 14.13 7.26  
Profit/Loss From Continuing Operations 19.68 16.78 12.62 14.13 7.26  
Profit/Loss For The Period 19.68 16.78 12.62 14.13 7.26  
OTHER ADDITIONAL INFORMATION  
EARNINGS PER SHARE  
Basic EPS (Rs.) 9.42 8.01 5.90 6.71 3.46  
Diluted EPS (Rs.) 9.42 8.01 5.90 6.71 3.46  
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS  
Imported Raw Materials 0.00 0.00 0.00 0.00 0.00  
Indigenous Raw Materials 0.00 0.00 0.00 0.00 0.00  
STORES, SPARES AND LOOSE TOOLS  
Imported Stores And Spares 0.00 0.00 0.00 0.00 0.00  
Indigenous Stores And Spares 0.00 0.00 0.00 0.00 0.00  
DIVIDEND AND DIVIDEND PERCENTAGE  
Equity Share Dividend 0.00 0.00 0.00 0.00 0.00  
Tax On Dividend 0.00 0.00 0.00 0.00 0.00  
Equity Dividend Rate (%) 0.00 0.00 0.00 0.00 0.00  
Source : Dion Global Solutions Limited

Results of Pharmaceuticals Sector

Advisory Alert:

It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347